Pancreatic cancer: the evolving role of systemic therapy

Author： El-Rayes Basil F Adsay N Volkan Philip Philip A

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.12, 2001-12, pp. : 1939-1947

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of adjuvant therapy for pancreatic cancer

By Hartley Mark Ghaneh Paula Sutton Robert Neoptolemos John P Magee Conor J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2001-01 ,pp. : 87-107

Informa Healthcare

Access to resources Recommend Favorite

Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 811-828

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the RAS in Pancreatic Cancer

Current Cancer Drug Targets, Vol. 11, Iss. 4, 2011-05 ,pp. : 412-420

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer)

Current Drug Targets, Vol. 17, Iss. 15, 2016-12 ,pp. : 1706-1706

Bentham Science Publishers

Access to resources Recommend Favorite

Mucins in the Diagnosis and Therapy of Pancreatic Cancer.

Current Pharmaceutical Design, Vol. 6, Iss. 18, 2000-12 ,pp. : 1881-1896

Bentham Science Publishers

Access to resources Recommend Favorite